Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies

Immune checkpoint inhibitors (ICIs) targeting PD-1 and CTLA-4 have achieved groundbreaking clinical success in multiple cancers; however, a large proportion of patients experience primary or acquired resistance. This review synthesizes the complex mechanisms underlying resistance to PD-1/CTLA-4 bloc...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Xiaodong Wang, Jing He, Gouping Ding, Yixuan Tang, Qianqian Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-10-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1688699/full